Dendreon

WASHINGTON - The Food and Drug Administration has approved a first-of-a-kind prostate cancer treatment that uses the body's immune system to fight the disease, offering an important alternative to decades-old approaches.

WASHINGTON - A first-of-a-kind prostate cancer treatment that uses the body's immune system to fight the disease received federal approval Thursday, offering an important alternative to more taxing treatments like chemotherapy.

Insurers stop selling new child-only health plans INDIANAPOLIS (AP) - Several health insurers say they will stop selling new child-only individual insurance policies as they face a health care reform provision that will prevent them from excluding children with potentially costly pre-existing conditions.